1. Home
  2. EARN vs MDXH Comparison

EARN vs MDXH Comparison

Compare EARN & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

N/A

Current Price

$4.60

Market Cap

200.3M

Sector

Real Estate

ML Signal

N/A

Logo MDxHealth SA

MDXH

MDxHealth SA

N/A

Current Price

$3.25

Market Cap

183.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
EARN
MDXH
Founded
2012
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
200.3M
183.4M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
EARN
MDXH
Price
$4.60
$3.25
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$5.38
$7.67
AVG Volume (30 Days)
600.7K
108.3K
Earning Date
06-05-2026
01-01-0001
Dividend Yield
20.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.43
$30.31
Revenue Next Year
$24.47
$18.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.33
$1.36
52 Week High
$6.08
$5.33

Technical Indicators

Market Signals
Indicator
EARN
MDXH
Relative Strength Index (RSI) 29.14 39.49
Support Level N/A $3.05
Resistance Level $5.36 $3.78
Average True Range (ATR) 0.15 0.17
MACD -0.03 -0.02
Stochastic Oscillator 21.18 5.36

Price Performance

Historical Comparison
EARN
MDXH

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: